香港交易所(00388.HK):姚嘉仁及莊博禮將獲委任為聯席營運總監
格隆匯5月6日丨香港交易所(00388.HK)發佈公吿,戴志堅先生將於2022年5月31日退休,並將退任香港交易所集團的所有職位;職位包括香港交易所首席營運總監,以及聯交所及期交所(聯交所及期交所均為香港交易所直接全資附屬公司)的行政總裁。
姚嘉仁及莊博禮(John Leo Buckley)將獲委任為香港交易所的聯席營運總監,並分別繼續擔任香港交易所市場聯席主管以及交易營運及企業轉型主管的職能。姚先生亦將接替戴先生出任聯交所及期交所的行政總裁。上述委任已獲香港證監會根據《證券及期貨條例》第70及第26條書面核准,並將於2022年6月1日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.